About Gallus Biopharma
Gallus Biopharma is a company based in St. Louis (United States) founded in 2010 was acquired by Dpx Holdings in August 2014.. Gallus Biopharma has completed 1 acquisition, including Laureate Biopharmaceutical Services. Gallus Biopharma operates in a competitive market with competitors including Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Dpx Holdings
& 1 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Dpx Holdings
(Aug 27, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
330 people
Leadership Team
169 people
Sales and Marketing
138 people
Human Resources and Administration
102 people
Product Management Team
68 people
Finance and Accounting
67 people
Senior Team
59 people
Operations Team
52 people
Unlock access to complete
Funding Insights of Gallus Biopharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2011 | Amount | Unspecified - Gallus Biopharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gallus Biopharma
Gallus Biopharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Dpx Holdings and Ridgemont Equity partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mid-market companies are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Dpx Holdings was founded in 2014 in Framingham, United States.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gallus Biopharma
Gallus Biopharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Laureate Biopharmaceutical Services. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biologics process development and cGMP manufacturing services are offered.
|
1981 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Gallus Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gallus Biopharma Comparisons
Competitors of Gallus Biopharma
Gallus Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Mammalian cell culture biologics are developed through contract research services.
|
|
| domain | founded_year | HQ Location |
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
|
|
| domain | founded_year | HQ Location |
Contract manufacturing solutions for biologics are provided to Asian companies.
|
|
| domain | founded_year | HQ Location |
Drug substance development, analytical, and compliance services are provided.
|
|
| domain | founded_year | HQ Location |
Biologics development and GMP manufacturing services are offered.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Gallus Biopharma
When was Gallus Biopharma founded?
Gallus Biopharma was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Gallus Biopharma located?
Gallus Biopharma is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
What does Gallus Biopharma do?
Gallus Biopharma, acquired by DPx Holdings, privately owned by JLL Partners and Royal DSM and the parent company of Patheon, was a biologics CDMO offering mammalian cell line based manufacturing services for drug developers. Their service portfolio included process development, analytical method development, process validation, quality assurance and regulatory affairs, cGMP manufacturing, fillfinish, project management services, stability testing, cell banking, and storage services. The company has 2 mammalian cell culture facilities in the US. It is currently part of Patheons biologic drug substance business which spans four global facilities in Europe, Australia and North America.
Who are the top competitors of Gallus Biopharma?
Gallus Biopharma's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
How many acquisitions has Gallus Biopharma made?
Gallus Biopharma has made 1 acquisition, including Laureate Biopharmaceutical Services.
Who are Gallus Biopharma's investors?
Gallus Biopharma has 2 investors. Key investors include Dpx Holdings, and Ridgemont Equity partners.